Quantedge Capital Pte LTD Innoviva, Inc. Transaction History

Quantedge Capital Pte LTD

  • $328 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$14.32 - $19.88 $2.23 Million - $3.1 Million
155,900 Added 280.4%
211,500 $3.12 Million
Q1 2022

May 13, 2022
BUY
$15.39 - $20.25 $603,288 - $793,800
39,200 Added 239.02%
55,600 $1.08 Million
Q4 2021

Feb 11, 2022
BUY
$15.91 - $18.72 $260,924 - $307,008
16,400 New
16,400 $283,000

Others Institutions Holding INVA

# of Institutions
228
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.22B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Quantedge Capital Pte LTD Portfolio

Follow Quantedge Capital Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quantedge Capital Pte LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email